These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 19563835)

  • 1. Hepatitis B virus immunotolerant patients: need to differentiate patients with or without liver disease.
    Kumar M; Sarin SK
    Gastroenterology; 2009 Aug; 137(2):742-3. PubMed ID: 19563835
    [No Abstract]   [Full Text] [Related]  

  • 2. Need to strictly define hepatitis B virus immunotolerant patients to avoid unnecessary liver biopsy.
    Andreani T; Serfaty L; Poupon R; Chazouilleres O
    Gastroenterology; 2008 Dec; 135(6):2155-6. PubMed ID: 19000682
    [No Abstract]   [Full Text] [Related]  

  • 3. Chronic hepatitis B virus carriers in the immunotolerant phase of infection: histologic findings and outcome.
    Andreani T; Serfaty L; Mohand D; Dernaika S; Wendum D; Chazouillères O; Poupon R
    Clin Gastroenterol Hepatol; 2007 May; 5(5):636-41. PubMed ID: 17428739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Relationships between liver function test, serum HBeAg or HBV DNA level and liver pathological changes in patients with chronic hepatitis B].
    Xu QH; Shu X; Chen LB; Huang HH; Zhang K; Li G
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Dec; 22(6):422-4. PubMed ID: 19544633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hepatitis B virus DNA in hepatitis B surface antigen-negative patients with chronic liver disease].
    Jilg W
    Dtsch Med Wochenschr; 1985 Jun; 110(25):1017-8. PubMed ID: 2408841
    [No Abstract]   [Full Text] [Related]  

  • 6. Serum markers of hepatitis B virus and anti-delta antibody in chronic liver disease.
    Buzzelli G; Alterini B; Monaco L; Gialdini D; Baronti E; Matassi L; Simondi P; Zignego AL; Gentilini P
    Quad Sclavo Diagn; 1985 Dec; 21(4):387-98. PubMed ID: 3837913
    [No Abstract]   [Full Text] [Related]  

  • 7. The immunology of hepatitis B.
    Vierling JM
    Clin Liver Dis; 2007 Nov; 11(4):727-59, vii-viii. PubMed ID: 17981227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Core promoter mutations of hepatitis B virus and hepatocellular carcinoma: story beyond A1762T/G1764A mutations.
    Liu CJ; Kao JH
    J Gastroenterol Hepatol; 2008 Mar; 23(3):347-50. PubMed ID: 18318819
    [No Abstract]   [Full Text] [Related]  

  • 9. [Chronic hepatitis B].
    Thimme R; Spangenberg HC; Blum HE
    Dtsch Med Wochenschr; 2008 Jan; 133(4):135-8. PubMed ID: 18197589
    [No Abstract]   [Full Text] [Related]  

  • 10. Hepatitis B e antigen-negative patients with persistently normal alanine aminotransferase levels and hepatitis B virus DNA > 2000 IU/mL.
    Dai CY; Chuang WL; Huang JF; Yu ML
    Hepatology; 2009 Feb; 49(2):704-5; author reply 705-6. PubMed ID: 19177587
    [No Abstract]   [Full Text] [Related]  

  • 11. Chronic seropositive polyarthritis associated with hepatitis B virus-induced chronic liver disease: a sequel of virus persistence.
    Csepregi A; Rojkovich B; Nemesánszky E; Poór G; Héjjas M; Horányi M
    Arthritis Rheum; 2000 Jan; 43(1):232-3. PubMed ID: 10643720
    [No Abstract]   [Full Text] [Related]  

  • 12. Hepatogastroenterologists' knowledge of inactive carriers and immunotolerant hepatitis B virus patients in France: results of a practice survey.
    Causse X; Cadranel JF; Potier P; Hanslik B; Denis J; Renou C; Delasalle P; ;
    Eur J Gastroenterol Hepatol; 2015 May; 27(5):544-9. PubMed ID: 25822863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of concurrent hepatitis B surface antigen and antibody to hepatitis B surface antigen with hepatocellular carcinoma in chronic hepatitis B virus infection.
    Jang JS; Kim HS; Kim HJ; Shin WG; Kim KH; Lee JH; Kim HY; Kim DJ; Lee MS; Park CK; Jeong BH; Kim YS; Jang MK
    J Med Virol; 2009 Sep; 81(9):1531-8. PubMed ID: 19623669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HBV Chronic hepatitis during chemotherapy - an immune controlled disease.
    Caruntu FA; Gheorghita V
    J Gastrointestin Liver Dis; 2008 Dec; 17(4):445-9. PubMed ID: 19104707
    [No Abstract]   [Full Text] [Related]  

  • 15. Combination of hepatitis B viral factors and advanced liver disease in HBeAg-negative patients: the more, the worse?
    Lin CL; Branch RA; Kao JH
    Gastroenterology; 2008 Apr; 134(4):1270-1; author reply 1271. PubMed ID: 18395114
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical significance of hepatitis B surface antigen in cord blood of hepatitis B e-antigen-negative chronic hepatitis B virus-infected mothers.
    Elefsiniotis IS; Papadakis M; Vlahos G; Daskalakis G; Saroglou G; Antsaklis A
    Intervirology; 2009; 52(3):132-4. PubMed ID: 19468236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The natural history and the staging of chronic hepatitis B: time for reevaluation of the virus-host relationship based on molecular virology and immunopathogenesis considerations?
    Thompson A; Locarnini S; Visvanathan K
    Gastroenterology; 2007 Sep; 133(3):1031-5. PubMed ID: 17854605
    [No Abstract]   [Full Text] [Related]  

  • 18. Seroepidemiology of hepatitis B virus in rural Tanzania: relation of hepatitis B markers and liver function tests in patients with clinical liver disease and in healthy controls.
    Stahel E; Tanner M; Gyr N; Weiss N; Hess C; Betschart B
    East Afr Med J; 1984 Nov; 61(11):806-11. PubMed ID: 6535703
    [No Abstract]   [Full Text] [Related]  

  • 19. Negative correlation between viral load and HBsAg levels in chronic HBV-infected patients.
    Ozdil B; Cosar AM; Akkiz H; Sandikci MU; Kece C
    Arch Virol; 2009; 154(9):1451-5. PubMed ID: 19672557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and virological survey of patients with hepatitis B surface antigen in an Italian region: clinical considerations and disease burden.
    Torre F; Basso M; Giannini EG; Feasi M; Boni S; Grasso A; De Leo P; Dodi F; Marazzi MG; Azzola E; Bartolacci V; Percario G; Beltrame A; Borro P; Picciotto A;
    J Med Virol; 2009 Nov; 81(11):1882-6. PubMed ID: 19774694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.